Ikonisys Announces the Completion of a Private Placement to Speed up Growth Following Recent Pivotal Deals - Seite 2

The Issuer has issued a total of 666,667 new ordinary shares, with a par value of €0.50 each, to a restricted circle of investors, pursuant to article L. 411-2 1° of the French Monetary and Financial Code, in accordance with the 8^th resolution passed by its Annual General Meeting on June 28, 2023.

The issuance price of the new shares issued under the Capital Increase, equal to €1.5 per share, represents a discount of approximately 13% on the Ikonisys share price at the close of December 27, 2023.

Impact of the transaction in terms of liquidity risk management and financing horizon

As at June 30, 2023, and as mentioned in the half-year financial statements published on October 31, 2023, the Issuer's consolidated cash position amounted to €66k.

Following the Capital Increase and including the existing financing facility secured in October 2022, the Company will be in a position to meet its financing needs for more than 12 months.

Impact of the Capital Increase on a shareholder holding 1% of the capital

On the basis of the 9,784,757 shares outstanding, the impact on the shareholding of a shareholder holding 1% of the Issuer's capital prior to the transaction is as follows:

	On a non-diluted basis	On a diluted basis1
Before completion of the Capital Increase	1.00%	0.96 %
After issuance of the 666,667 shares resulting from the Capital Increase	0.94 %	0.90 %

¹ Dilution takes into account the exercise of all outstanding dilutive instruments likely to result in the issuance of a maximum indicative number of 426,673 new shares.

Capital breakdown before and after completion of the Capital Increase

Before the Capital Increase:

Shareholder	Number of shares	% of share capital and voting rights
Cambria Co-Investment Fund	5,268,989	53.85%
Cambria Equity Partners	2,374,049	24.26%
MC Consulting*	351,464